top of page

Dried blood spot vs capillary tube collection: how to choose a sample type for at-home lab programs

35 minutes ago
5 min read
Ink and wash illustration of a lab team comparing at-home blood sample types: a scientist examines a dried blood spot card, a technician racks small capillary blood tubes beside an analyzer, and an at-home collection kit and mailer sit on the bench

Dried blood spot (DBS) cards and capillary blood tubes both let patients collect a small blood sample at home, but they suit different tests. DBS cards are light, stable and easy to mail. Capillary tubes deliver a liquid sample closer to a standard serum or plasma workflow. The right choice depends on each test's validation, not on preference.


This guide is for telehealth platforms, longevity and wellness brands, and research teams planning at-home lab programs. It explains how each sample type works, the trade-offs that matter in practice, and what to ask a lab before you commit to a kit design. It is general information, not medical advice.



How the two sample types work



Dried blood spot cards


A patient pricks a fingertip with a lancet and lets drops of blood fall onto marked circles on a filter-paper card. The card dries at room temperature for several hours before it is sealed and mailed. At the lab, technicians punch fixed-size discs from the spots and extract the analytes for testing, as described in a 2023 review of blood microsampling technologies in Analytical Science Advances.


DBS is not new. It is the long-established sample type for newborn screening, and the Clinical and Laboratory Standards Institute maintains a dedicated collection standard, CLSI NBS01 (7th edition, 2021), that covers spot application, drying, handling and transport, with images of unacceptable specimens.



Capillary blood tubes


The patient uses the same kind of fingerstick, but collects the blood into a small tube instead of onto paper. The tube goes back to the lab as a liquid sample, where it can be processed much like a conventional serum or plasma specimen. That makes it a closer fit for many routine chemistry and hormone assays, at the cost of a little more effort from the patient and tighter shipping requirements.



Trade-offs that matter for a program



Stability and shipping


DBS has a clear logistics advantage. A 2020 review in the journal Diagnostics lists small sample volumes, no special storage or transport conditions, and improved analyte stability among its main benefits. The same review notes limits: humidity can degrade samples, so dried cards are best kept in sealed bags with a desiccant, and some unstable compounds still need cold storage.


Liquid capillary samples generally need to reach the lab within a validated time and temperature window. That affects your shipping method, which days kits can go out, and how you handle returns that arrive late.



Accuracy and the hematocrit effect


The main analytical challenge with DBS is hematocrit, the share of blood volume made up of red blood cells. Blood with a higher hematocrit spreads less on the paper, so a fixed-size punch can contain a different amount of blood than expected. A review in the journal EJIFCC describes how this can push results above or below what a "normal" sample would show, especially at very high or very low hematocrit.


Labs manage this by validating each DBS test across a realistic hematocrit range and by comparing DBS results with paired standard samples. Capillary tubes avoid the spot-size problem because the lab measures a liquid volume directly.



Test menu fit


Neither format covers every test. Some assays are validated on DBS, some only on liquid capillary blood, and some on both. Others are not validated for any home collection and still need a venous draw by a trained collector. A program that mixes tests in one kit may need two collection components, or may need to drop a test.



Patient experience


DBS asks the patient to fill several circles evenly without smearing or layering drops. Capillary tubes ask for a steady flow of blood up to a fill line. Both depend on clear instructions, warm hands and good lancets. Your sample rejection rate will reflect how well your kit and instructions handle these steps, so ask the lab to share how it tracks rejected specimens.



Side-by-side summary


  • Sample: DBS is dried whole blood on paper. A capillary tube is liquid blood that the lab processes like a standard specimen.

  • Shipping: DBS is light and generally tolerant of ambient transport once dry. Capillary tubes usually need a validated transit window.

  • Accuracy watch-outs: DBS must account for hematocrit and spot quality. Capillary tubes depend on fill volume and timely delivery.

  • Menu: Each test is validated on one format, both, or neither. Check test by test.

  • Best fit: DBS often suits lean kits and programs shipping long distances. Capillary tubes often suit broader chemistry and hormone panels.



What CLIA means for sample type choices


Under CLIA, the lab's validation work is what makes a home sample type usable. If a lab modifies an FDA-cleared or approved test system, such as running it on a sample type the manufacturer didn't validate, it must establish its own performance specifications before reporting patient results. That includes accuracy, precision, reportable range and reference intervals, under 42 CFR 493.1253.


CLIA also requires written procedures for specimen collection, labeling, storage, transport, and acceptance or rejection. Labs that accept referred specimens must give clients written instructions covering those steps, under 42 CFR 493.1242. For a kit program, those instructions are the foundation of your patient-facing directions.



Questions to ask a lab partner


  1. For each test we want, which home sample types are validated: DBS, capillary tube, or neither?

  2. How were DBS tests validated against standard samples, and across what hematocrit range?

  3. Do DBS and capillary results use the same reference intervals as venous results, or separate ones?

  4. What are the time and temperature limits for returning each sample type?

  5. What are your specimen rejection criteria, and how do you report and track rejections?

  6. Can one kit combine sample types, and how is that labeled and tracked?

  7. What happens when a sample is rejected: who tells the patient, and how is a replacement kit sent?

  8. Which states can you serve, and what licenses do you hold?



Planning notes


  • Start from the test list, not the device. Pick the clinical or program goal, then let validated sample types decide the kit.

  • Keep trends on one format. Switching a patient between DBS and liquid samples can make trends harder to read. Choose one per test and stick with it.

  • Budget for recollection. Some samples will be rejected. Plan who contacts the patient and how quickly a new kit ships.

  • Test the instructions. Have staff and pilot users collect samples before launch, and revise anything that causes errors.


If you're still mapping the rest of your operation, our guide to lab test kit fulfillment covers kitting, shipping and returns.


IHDLab is a CLIA-certified lab licensed in California, New York and Maryland. Its at-home test menu lists the collection type for each test, and its white-label test kits use dried blood spot cards or capillary tubes depending on the test. If you're weighing sample types for a new program, our team is happy to talk it through.

bottom of page